Walter Elrod, MD | |
611 W. Park St., Emergency Med., Urbana, IL 61801-2500 | |
(217) 383-3313 | |
(217) 383-4014 |
Full Name | Walter Elrod |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Experience | 27 Years |
Location | 611 W. Park St., Urbana, Illinois |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235199738 | NPI | - | NPPES |
2095950 | Medicaid | OH | |
4429887 | Medicaid | MI | |
000000271432 | Other | OH | ANTHEM |
341960760027 | Other | OH | CARESOURCE |
727137 | Other | OH | BCHP |
810547599035 | Medicaid | OH | |
000000372958 | Other | OH | ANTHEM |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 35-07-5044 (Ohio) | Secondary |
207P00000X | Emergency Medicine | 036140323 (Illinois) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Gulf Breeze Hospital | Gulf breeze, FL | Hospital |
Lima Memorial Health System | Lima, OH | Hospital |
Baptist Hospital | Pensacola, FL | Hospital |
The Carle Foundation Hospital | Urbana, IL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Pensacola Emergency Physicians, Llc | 3173582624 | 31 |
Baptist Physician Associates Llc | 3577518398 | 7 |
Emergency Physicians Of Northwest Ohio, Inc. | 3375456478 | 92 |
News Archive
More than half of the antipsychotics paid for by Medicare in the first half of 2007 were "erroneous," the audit found, costing the program $116 million during those six months.
A new study finds that smokers in rural Indonesia finance their habit by dipping into the family food budget-which ultimately results in poorer nutrition for their children. The findings suggest that the costs of smoking in the developing world go well beyond the immediate health risks, according to authors Steven Block and Patrick Webb of Tufts University.
Bend Research Inc., PATH, and Fraunhofer USA Center for Molecular Biotechnology (FhCMB) announce the development of a new technology for the production of thermostable vaccines. Utilizing novel formulation and spray-drying processing methods, the technology has enabled scientists at Bend Research, PATH, and FhCMB to develop a spray-dried influenza vaccine product that is stable at 50°C for over 2 months. The technology can also be applied to emerging influenza and other vaccines.
Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced preliminary results indicating that their human Alzheimer's disease (AD) diagnostic assay can detect a signal from aggregated beta amyloid in the spinal fluid (CSF) from AD patients.
Biopharmaceutical company Xenome Limited today announced it has received a convertible note placement of US$6 million from GBS Venture Partners, a Melbourne based life sciences specialist that invests in unlisted and listed high growth companies involved in innovative technologies.
› Verified 6 days ago
Entity Name | Pensacola Emergency Physicians, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1801841473 PECOS PAC ID: 3173582624 Enrollment ID: O20041008000951 |
News Archive
More than half of the antipsychotics paid for by Medicare in the first half of 2007 were "erroneous," the audit found, costing the program $116 million during those six months.
A new study finds that smokers in rural Indonesia finance their habit by dipping into the family food budget-which ultimately results in poorer nutrition for their children. The findings suggest that the costs of smoking in the developing world go well beyond the immediate health risks, according to authors Steven Block and Patrick Webb of Tufts University.
Bend Research Inc., PATH, and Fraunhofer USA Center for Molecular Biotechnology (FhCMB) announce the development of a new technology for the production of thermostable vaccines. Utilizing novel formulation and spray-drying processing methods, the technology has enabled scientists at Bend Research, PATH, and FhCMB to develop a spray-dried influenza vaccine product that is stable at 50°C for over 2 months. The technology can also be applied to emerging influenza and other vaccines.
Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced preliminary results indicating that their human Alzheimer's disease (AD) diagnostic assay can detect a signal from aggregated beta amyloid in the spinal fluid (CSF) from AD patients.
Biopharmaceutical company Xenome Limited today announced it has received a convertible note placement of US$6 million from GBS Venture Partners, a Melbourne based life sciences specialist that invests in unlisted and listed high growth companies involved in innovative technologies.
› Verified 6 days ago
Entity Name | Baptist Physician Associates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235128646 PECOS PAC ID: 3577518398 Enrollment ID: O20050315000387 |
News Archive
More than half of the antipsychotics paid for by Medicare in the first half of 2007 were "erroneous," the audit found, costing the program $116 million during those six months.
A new study finds that smokers in rural Indonesia finance their habit by dipping into the family food budget-which ultimately results in poorer nutrition for their children. The findings suggest that the costs of smoking in the developing world go well beyond the immediate health risks, according to authors Steven Block and Patrick Webb of Tufts University.
Bend Research Inc., PATH, and Fraunhofer USA Center for Molecular Biotechnology (FhCMB) announce the development of a new technology for the production of thermostable vaccines. Utilizing novel formulation and spray-drying processing methods, the technology has enabled scientists at Bend Research, PATH, and FhCMB to develop a spray-dried influenza vaccine product that is stable at 50°C for over 2 months. The technology can also be applied to emerging influenza and other vaccines.
Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced preliminary results indicating that their human Alzheimer's disease (AD) diagnostic assay can detect a signal from aggregated beta amyloid in the spinal fluid (CSF) from AD patients.
Biopharmaceutical company Xenome Limited today announced it has received a convertible note placement of US$6 million from GBS Venture Partners, a Melbourne based life sciences specialist that invests in unlisted and listed high growth companies involved in innovative technologies.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Walter Elrod, MD 611 W. Park St., Bwpc, Urbana, IL 61801-2500 Ph: (217) 383-6941 | Walter Elrod, MD 611 W. Park St., Emergency Med., Urbana, IL 61801-2500 Ph: (217) 383-3313 |
News Archive
More than half of the antipsychotics paid for by Medicare in the first half of 2007 were "erroneous," the audit found, costing the program $116 million during those six months.
A new study finds that smokers in rural Indonesia finance their habit by dipping into the family food budget-which ultimately results in poorer nutrition for their children. The findings suggest that the costs of smoking in the developing world go well beyond the immediate health risks, according to authors Steven Block and Patrick Webb of Tufts University.
Bend Research Inc., PATH, and Fraunhofer USA Center for Molecular Biotechnology (FhCMB) announce the development of a new technology for the production of thermostable vaccines. Utilizing novel formulation and spray-drying processing methods, the technology has enabled scientists at Bend Research, PATH, and FhCMB to develop a spray-dried influenza vaccine product that is stable at 50°C for over 2 months. The technology can also be applied to emerging influenza and other vaccines.
Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced preliminary results indicating that their human Alzheimer's disease (AD) diagnostic assay can detect a signal from aggregated beta amyloid in the spinal fluid (CSF) from AD patients.
Biopharmaceutical company Xenome Limited today announced it has received a convertible note placement of US$6 million from GBS Venture Partners, a Melbourne based life sciences specialist that invests in unlisted and listed high growth companies involved in innovative technologies.
› Verified 6 days ago
Dr. Imran Khan, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 611 W Park St, Urbana, IL 61801 Phone: 217-383-3313 Fax: 217-383-4014 | |
Brendan Mcevoy, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 611 W Park St, Urbana, IL 61801 Phone: 217-383-3285 | |
Michael F Hegarty, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 W. Park Street, Emergency Medicine, Urbana, IL 61801 Phone: 217-383-4930 Fax: 217-383-4014 | |
Lars Grant, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1400 W Park St, Emergency Department, Urbana, IL 61801 Phone: 217-337-2131 | |
Philip Disalvo, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 611 W Park St, Urbana, IL 61801 Phone: 217-383-3313 Fax: 217-383-4014 | |
Dr. G. Michael M Swindle, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 W. Park Street, Emergency Medicine, Urbana, IL 61801 Phone: 217-383-3311 | |
Jose Ochoa, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 611 W Park St, Er, Urbana, IL 61801 Phone: 217-383-3313 Fax: 217-383-4014 |